The SARS-CoV-2 virus, which emerged as an unknown pneumonia-like disease in December 2019, gained the status of a global health crisis, by March 2020. Enforced lockdowns caused temporary shutdown of labs and production facilities. Next, the i...

The return from pharmaceutical innovation has seen a steady decline over the past few decades. Sales per asset continues to grow at a slower pace compared to the cost of discovery, development and manufacturing of drugs. Artificial intelligen...

The global pharmaceutical landscape is undergoing a massive overhaul with the advent of new technologies and cheaper and more efficient manufacturing techniques. This is paving the way for a whole new world of user-conscious drugs of the futu...

Biosimilars are a growing area in the pharmaceutical field and are set to expand over the next decade. According to Netscribes research, by 2022, the global biosimilar market is expected to reach USD 36 billion, while the biologic market is e...

Contact Us
X
  • I agree to receive updates on the latest industry trends, products and services from Netscribes.
  • We respect your right to data privacy and security. You may unsubscribe from our communications at any time. For more information, check out our Privacy Policy.